Istituto Tumori Bari
In research, Istituto Tumori Bari stands highest in Medicine (#3,856 of 10,443 worldwide) and Health Sciences (#5,197 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 16.1× its share of world research.
- World rank, 2022–2025
- #8,454 of 28,054 · #12,686 all time
- Rank in Italy
- #243 of 618
- Research works
- 763 ▲ 13% vs 2013–17
- Citations
- 18k 23.2 per fractional work
- Top-10% rate
- 22.8% record average 16.5%
- Open access
- 58% world 28%
What is Istituto Tumori Bari known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,856 of 10,443 | 23.3% | 128 | #5906 | |
| Health SciencesDomain | #5,197 of 11,982 | 22.9% | 133 | #7871 |
Each strip is that field’s whole ranked pool, with the notch where Istituto Tumori Bari sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Istituto Tumori Bari specialise in?
Where its research is concentrated relative to its size: Oncology takes 16.1× the share of its output that it takes of world research.
- OncologySubfield · 33.9 works16×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
- Medicine 3.5×
- Immunology and Microbiology 3.4×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Nursing 1.4×
- Health Professions 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Computer Science 0.4×
- Neuroscience 0.4×
- Economics, Econometrics and Finance 0.4×
- Dentistry 0.3×
- Chemistry 0.3×
- Veterinary 0.3×
- Mathematics 0.2×
- Psychology 0.2×
- Engineering 0.1×
- Chemical Engineering 0.1×
- Social Sciences 0.1×
- Materials Science 0.1×
- Arts and Humanities 0.1×
- Decision Sciences 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.1×
- Earth and Planetary Sciences 0.0×
- Physics and Astronomy 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Istituto Tumori Bari?
Ranked on the composite score, Attilio Guarini, Oronzo Brunetti and Michele Guida lead among researchers whose main affiliation is Istituto Tumori Bari.
- 1 Attilio Guarini Italy · #272,431 worldwide 100 citations · 41 works
- 2 Oronzo Brunetti Italy · #416,328 worldwide 56 citations · 26 works
- 3 Michele Guida Italy · #472,642 worldwide 93 citations · 41 works
- 4 Domenico Galetta Italy · #499,847 worldwide 92 citations · 58 works
- 5 Raffaella Massafra Italy · #521,661 worldwide 53 citations · 24 works
- 6 Stefania Tommasi Italy · #523,818 worldwide 67 citations · 26 works
- 7 Giuseppe Colucci Italy · #566,205 worldwide 42 citations · 34 works
- 8 Stefano Oliva Italy · #568,311 worldwide 18 citations · 20 works
- 9 Raffaele De Luca Italy · #696,977 worldwide 34 citations · 35 works
- 10 Emanuele Naglieri Italy · #754,769 worldwide 39 citations · 19 works
Which keywords describe research at Istituto Tumori Bari?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Tumor Microenvironment, Clinical Trials, Metastasis, Prognostic Factors, Cancer and Biomarkers.
- Texture Analysis
- Radiation Therapy
- Predictive Modeling
- PET Imaging
- Lymphoma
- Molecular Subtypes
- Feature Extraction
- Mutation Analysis
- Cytoreductive Surgery
- Cancer Therapy
- Ovarian Cancer
- PD-1 and PD-L1
- Breast Cancer
- Neoadjuvant Therapy
- Survival Analysis
- Clinical Practice Guidelines
- Prognostic Factors
- Metastasis
- Cancer
- Immunotherapy
- Chemotherapy
- Tumor Microenvironment
- Clinical Trials
- Epidemiology
- Biomarkers
- Machine Learning
- Targeted Therapy
- Precision Medicine
- Immune Checkpoint Blockade
- Gene Expression
- Radiotherapy
- Genomic Analysis
- Fallopian Tube Origin
- Tumor Models
- Molecular Characterization
- Rituximab
- Cholangiocarcinoma
- Prognostic Markers
- Quantitative Analysis
- Sentinel Lymph Node Biopsy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy25▲ 19×24 topics
- Immunotherapy18▲ 14×19 topics
- Tumor Microenvironment15▲ 18×8 topics
- Cancer14▲ 5.6×33 topics
- Clinical Trials14▲ 11×12 topics
- Metastasis14▲ 21×10 topics
- Epidemiology14▲ 1.82×55 topics
- Prognostic Factors13▲ 16×12 topics
- Biomarkers12▲ 9.2×9 topics
- Clinical Practice Guidelines11▲ 11×11 topics
- Machine Learning11▲ 1.78×15 topics
- Survival Analysis10▲ 19×6 topics
- Targeted Therapy9▲ 23×5 topics
- Neoadjuvant Therapy9▲ 21×5 topics
- Precision Medicine9▲ 9.8×7 topics
- Breast Cancer8▲ 19×10 topics
- Immune Checkpoint Blockade8▲ 38×1 topic
- PD-1 and PD-L18▲ 38×1 topic
- Gene Expression8▲ 6.7×9 topics
- Ovarian Cancer7▲ 44×3 topics
- Radiotherapy7▲ 9.9×11 topics
- Cancer Therapy6▲ 5.8×13 topics
- Genomic Analysis6▲ 13×4 topics
- Cytoreductive Surgery5▲ 44×2 topics
- Fallopian Tube Origin5▲ 61×1 topic
- Mutation Analysis5▲ 37×1 topic
- Tumor Models5▲ 48×2 topics
- Feature Extraction5▲ 5.9×4 topics
- Molecular Characterization5▲ 15×5 topics
- Molecular Subtypes5▲ 32×3 topics
- Rituximab5▲ 17×4 topics
- Lymphoma5▲ 16×3 topics
- Cholangiocarcinoma4▲ 30×2 topics
- PET Imaging4▲ 14×4 topics
- Prognostic Markers4▲ 23×3 topics
- Predictive Modeling4▲ 8.6×2 topics
- Quantitative Analysis4▲ 12×2 topics
- Radiation Therapy4▲ 18×5 topics
- Sentinel Lymph Node Biopsy4▲ 27×2 topics
- Texture Analysis4▲ 10×2 topics
Which research topics does Istituto Tumori Bari publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Ovarian cancer diagnosis and treatment, Radiomics and Machine Learning in Medical Imaging and Breast Cancer Treatment Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 5 works
- 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
- 4 Breast Cancer Treatment Studies Cancer Research 4 works
- 5 Lung Cancer Research Studies Oncology 4 works
- 6 Pancreatic and Hepatic Oncology Research Oncology 3 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 8 AI in cancer detection Artificial Intelligence 3 works
- 9 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 3 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Istituto Tumori Bari's research output changed?
Output in 2018–2022 was 13% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bari
- University of Bari Aldo Moro
- Polytechnic University of Bari
- Ospedale San Paolo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari
- Ospedale Santa Maria
- Institute of Crystallography
- Gastroenterology Hospital "Saverio de Bellis"
- Institute of Sciences of Food Production
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.